1. Home
  2. Labeler Index
  3. Ani Pharmaceuticals, Inc.
  4. 70954-168
  5. Product Images: Sildenafil

Product Images Sildenafil

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 21 images provide visual information about the product associated with Sildenafil NDC 70954-168 by Ani Pharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Figure A - Fig IFU A

Figure A - Fig IFU A

This text contains a diagram or image with some text in it that could not be recognized correctly by the software. Hence, the description cannot be generated.*

Figure B - Fig IFU B

Figure B - Fig IFU B

Figure C - Fig IFU C

Figure C - Fig IFU C

Figure D - Fig IFU D

Figure D - Fig IFU D

Figure E - Fig IFU E

Figure E - Fig IFU E

Figure F - Fig IFU F

Figure F - Fig IFU F

Figure G - Fig IFU G

Figure G - Fig IFU G

Figure3 - Figure 1

Figure3 - Figure 1

Figure1 - Figure 201

Figure1 - Figure 201

Figure7 - Figure7

Figure7 - Figure7

This text provides information about the interactions between drugs and their possible effects, focusing on the fold change and 90% CI recommendation. It lists several drugs such as Atorvastatin, Azithromycin, Bosentan, Cimetidine, Erythromycin, Maslox, Oral Contraceptives, Ritonavir, and Saquinavir with their recommended dose adjustment and/or accumulation ratio. There is also information regarding the benefits of sildenafil added to bosentan therapy.*

Figure8 - Figure8

Figure8 - Figure8

Figure_10 - Figure 10

Figure_10 - Figure 10

This appears to be a medical report with some numerical values and abbreviations. The report mentions the use of "Placsbo Sudenats" and "Sidorati 20 mg TID" which may be medications or treatments for a certain condition. The report also includes details about "Basaline walk distance" and "PAR" which could be used to evaluate the patient's physical ability or heart health. However, due to incomplete and unclear information, it is not possible to provide a useful description.*

Figure_11 - Figure 11

Figure_11 - Figure 11

Figure_12 - Figure 12

Figure_12 - Figure 12

Figure_2 - Figure 2

Figure_2 - Figure 2

Figure_5 - Figure 5

Figure_5 - Figure 5

Figure_6 - Figure 6

Figure_6 - Figure 6

Figure_9 - Figure 9

Figure_9 - Figure 9

This appears to be a table showing the change from baseline in meters during a study conducted over 12 weeks. The table includes different treatment groups, including those receiving a placebo and different doses of sildenafil. There are no further details available.*

Structure - Structure

Structure - Structure

newcarton

newcarton

newcontainer

newcontainer

This is a prescription medication that contains sildenafil citrate and is administered orally in a suspension form. It is stored below 30°C (86°F) before reconstitution and after, it should either be stored below 30°C (86°F) or in a refrigerator between 2°C to 8°C (36°F - 46°F). The product should be used within 60 days after reconstitution, and it should not be frozen. Each bottle contains 1.57 grams of sildenafil citrate (1.12 g of sildenafil) in 112 mL of suspension. The usual dosage should be determined by the prescribing physician and is provided on the packaging insert. The suspension is grape-flavored, and it should be shaken well before each use. The product is manufactured by Novitium Pharma LLC, and the most recent revision was in March 2020.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.